Clinical Trial Update: [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

View source ↗

Summary

Clinical trial update for a retrospective study using the radiotracer [18F]FET PET to characterize progressive or recurrent glioma after treatment-related chang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioma

Drugs mentioned

• [18F]FET (O-(2-[18F]fluoroethyl)-L-tyrosine)

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Retrospective Study, Glioma | Status: ACTIVE_NOT_RECRUITING